Korio
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $3.5M
Investors
- 3
About Korio
Based in Pennsylvania, US, and founded in 2021 by its CEO Ryan Keane, and COO Chuck Harris, Korio Inc. operates as a company in the field of clinical trial management, offering interactive response technology (IRT) solutions. In September 2023, Korio Inc. Korio Inc. develops an interactive response technology platform that offers subject and supply management for all trial designs, reduces customer time and effort, enhances quality, and accessible audit trails. The platform promotes study setup reusability, enabling the automatic reuse of study settings and system configurations from previous clinical trials. It also offers roles-based navigation, auto-generation of IRT requirements, and an integrations setup wizard to sync data with clinical systems more efficiently.
Who invested in Korio
3 investors across 2 rounds
See all investors in Korio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Korio
Who invested in Korio?
Korio has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Korio raised?
Korio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Korio last raise money?
Korio's most recent round on record is a Series A, in Sep 2024.
What does Korio do?
Based in Pennsylvania, US, and founded in 2021 by its CEO Ryan Keane, and COO Chuck Harris, Korio Inc.
Where is Korio headquartered?
Korio is headquartered in Doylestown, US.
Which VCs invest in companies like Korio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Korio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Korio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.